Tdp0 Small Handheld Operation Tablet Press Pill Manual Machine

Name: Tdp0 Small Handheld Operation Tablet Press Pill Manual Machine
Brand: Jining Factop International Trade Co., Ltd.
SKU: 1982574731

Shandong, ChinaJining Factop International Trade Co., Ltd.

US$300.00

1-4 Sets

US$250.00

5+ Sets

Product profile

Customization

Available

Automation Level

Manual

Capacity

1000 tablets/hour

Model NO.

TDP0

Certification

CE Certified, GMP Compliant, GMP

Tablet Shape

Oval, Rectangular, Round, Square

Warranty

1 Year

Finished Dosage Form

Tablet, Pill

Precision

High Precision

Computerized

Customized

Condition

New

Type

Pharmaceutical Machinery

Transport Package

Wooden Packing

Specification

30kg

Trademark

Origin

Shanghai

HS Code

8479109000

Production Capacity

1000sets/Week

Key features

High Precision Output: Delivers consistent tablet quality with high precision engineering.

GMP Compliant Design: Meets strict GMP standards for use in regulated pharmaceutical environments.

Manual Operation: Simple desktop manual machine requiring no electricity for operation.

Customizable Tablet Shapes: Produces round, oval, rectangular, or square tablets by changing molds.

Compact and Portable: Small volume, light weight design ideal for R&D and small-batch production.

Wide Industry Application: Suitable for pharmaceutical, chemical, food, and electronics industries.

1-Year Warranty: Includes a comprehensive 1-year warranty for peace of mind.

High Production Capacity: Capable of producing up to 2000 tablets per hour depending on specifications.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceFast DeliveryMinor Customization

Jining Factop International Trade Co., Ltd.

Shandong, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2014-06-20Nearest Port: Shanghai, NingboAverage Response Time: ≤0.62hTerms of Payment: T/T, Western Union, Money GramInternational Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DDP, DAP, FCA

AI-Powered supplier vetting

SummaryThe supplier manufactures pharmaceutical and packaging machinery, including blister packing, sugar coating, tablet counting, and related production equipment. Its products are exported to the United States, Europe, the Middle East, Southeast Asia, and North America, with exports representing 51%–70% of total sales and eight years of exporting experience. Production and delivery indicators are partially positive, including peak- and off-season lead times within 15 workdays and stated quality assurance with raw-material traceability. However, the supplier has no documented corrective-action or complaint-handling procedures, no supplier-service assessment records, no listed management-system certification, no overseas service infrastructure, no inventory service capability, and no new products launched during the previous year. R&D and design resources appear limited, with one R&D engineer and minor customization capability. Customer retention is reported at 50%–80%, but specific customer cases are not provided.

Supplier typeThe supplier is a manufacturer and developer of pharmaceutical production and packaging machinery, including blister packing, sugar coating, tablet counting, and powder-to-tablet/capsule equipment. It sells domestically and exports to the United States, Europe, the Middle East, Southeast Asia, and North America, with eight years of export experience and stated self-operated import/export rights.

CertificationsThe supplier states that its tablet-press digital control system supports alignment with cGMP and FDA requirements, but the available information does not identify a certification held by the supplier. Supplier management-system certification is explicitly listed as NIL, so no formal certification holding is evidenced.

After-Sales capabilityThe supplier cites good after-sales service as a company tenet and accepts multiple quotation terms, but it has no written corrective/preventive-action procedures, no written customer-complaint procedures or records, and no written service-capability assessment procedure. It also reports no overseas agents or branches, overseas warehouse, showroom, inventory capability, or overseas service countries, indicating limited documented and local service infrastructure.

R&D capabilityThe supplier reports integrated development and production capabilities and describes high-tech machinery development, but it has only one R&D engineer, one year of total R&D-engineer experience is reported, and no new products were launched during the previous year. These explicit indicators show limited recent innovation output.

Production capacityThe supplier reports integrated manufacturing of several pharmaceutical machinery categories, exports representing 51%–70% of sales, annual production output above the stated threshold, and lead times within 15 workdays in both peak and off-season periods. Quality assurance and raw-material traceability are reported, although finished products are randomly inspected and checked by packing staff, which limits the evidence of a robust final-inspection system.

Customization capabilityThe supplier explicitly offers minor customization. No evidence is provided of moderate or extensive engineering customization, so the demonstrated capability is limited to minor modifications.